Tristetraprolin-mediated mRNA destabilization regulates basophil inflammatory responses

Area of Science:

• Immunology
• Molecular Biology
• Allergy Research

Background:

• Basophils are key in type 2 immunity and allergic inflammation.
• Molecular regulation of basophil activation and mediator production is poorly understood.
• Tristetraprolin (TTP) is an RNA-binding protein investigated for its role in basophils.

Purpose of the Study:

• To investigate the role of tristetraprolin (TTP) in regulating inflammatory molecule production in basophils.
• To understand the molecular mechanisms of basophil activation.
• To evaluate TTP's in vivo significance in allergic inflammation.

Main Methods:

• Basophil stimulation (antigen/IgE, IL-33, LPS) in wild-type and TTP-knockout mice.
• Bulk RNA sequencing and transcriptome-wide mRNA stability assays.
• In vivo studies using basophil-specific TTP-deficient mice and an atopic dermatitis model.

Main Results:

• TTP expression increased upon basophil stimulation.
• TTP-knockout basophils showed elevated inflammatory gene/protein production.
• TTP deficiency prolonged inflammatory mRNA half-life.
• Basophil-specific TTP deficiency exacerbated allergic skin inflammation.

Conclusions:

• TTP is a critical regulator of basophil activation via mRNA destabilization.
• Absence of TTP in basophils significantly worsens allergic skin inflammation.
• TTP represents a potential therapeutic target for allergic diseases.